Teladoc Health, Inc. - Common Stock (TDOC)

Historical Holders from Q2 2015 to Q3 2025

Symbol
TDOC on NYSE
CUSIP
87918A105
Type / Class
Equity / Common Stock
Shares outstanding
175M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
128M
Holdings value
$1.11B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
347
Number of buys
150
Number of sells
-179
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Teladoc Health, Inc. - Common Stock (TDOC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 11.98% $160M 21M The Vanguard Group Jun 30, 2025
BlackRock, Inc. 7.8% $107M 13.6M BlackRock, Inc. Mar 31, 2025
Point72 Asset Management, L.P. 5% +17.5% $64.7M $9.96M 8.83M +18.2% Point72 Asset Management, L.P. May 16, 2025

Institutional Holders of Teladoc Health, Inc. - Common Stock (TDOC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.89K $14.6K +$1.11K $7.73 1
2025 Q2 128M $1.11B +$28.9M $8.71 347
2025 Q1 125M $993M -$13.2M $7.96 367
2024 Q4 127M $1.15B +$5.54M $9.09 364
2024 Q3 125M $1.15B -$101M $9.18 354
2024 Q2 139M $1.36B +$86M $9.78 389
2024 Q1 129M $1.95B +$10.8M $15.10 410
2023 Q4 141K $3.04M +$1.95M $21.58 4
2023 Q3 120M $2.23B -$121M $18.59 408
2023 Q2 127M $3.22B -$237M $25.32 410
2023 Q1 136M $3.52B +$69M $25.90 407
2022 Q4 135M $3.18B -$83.5M $23.65 409
2022 Q3 138M $3.49B -$105M $25.35 408
2022 Q2 141M $4.7B +$65.6M $33.21 474
2022 Q1 138M $9.98B -$41.9M $72.13 623
2021 Q4 139M $12.8B -$124M $91.82 674
2021 Q3 133M $16.9B +$645M $126.81 731
2021 Q2 127M $21.2B +$1B $166.29 804
2021 Q1 121M $22B +$1.07B $181.75 861
2020 Q4 99.6M $19.9B +$5.93B $199.96 853
2020 Q3 75.5M $16.5B +$918M $219.24 722
2020 Q2 68M $13B -$206M $190.84 644
2020 Q1 72.7M $11.3B -$2.13B $155.01 552
2019 Q4 86.5M $7.24B -$315M $83.72 399
2019 Q3 90.8M $6.15B +$308M $67.72 361
2019 Q2 86.2M $5.71B +$229M $66.41 354
2019 Q1 84.3M $4.68B +$196M $55.60 351
2018 Q4 81.5M $4.04B +$66M $49.57 316
2018 Q3 78.5M $6.78B +$278M $86.35 327
2018 Q2 75.9M $4.4B -$62.3M $58.05 270
2018 Q1 77.1M $3.1B +$70.3M $40.30 227
2017 Q4 75.6M $2.63B +$299M $34.85 202
2017 Q3 65.3M $2.17B +$268M $33.15 176
2017 Q2 57.3M $1.99B +$288M $34.70 163
2017 Q1 50.3M $1.26B +$614M $25.00 128
2016 Q4 28.8M $476M +$62.3M $16.50 107
2016 Q3 24.6M $450M +$92.9M $18.31 101
2016 Q2 18.5M $296M +$65.1M $16.02 84
2016 Q1 15.7M $151M -$36.7M $9.60 76
2015 Q4 18.7M $335M -$60.4M $17.96 73
2015 Q3 20.9M $458M +$451M $22.29 88
2015 Q2 266K $5.01M +$5.01M $19.00 14